1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. VERACYTE INC
Veracyte Inc XNAS: VCYT

Veracyte Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate)...

Read More
43.05 -0.40 (-0.92%)
90.40% Gain from 52W Low
603.5K
XNAS Volume

XNAS 13 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Veracyte Inc is on 15 Jan 2026 for the purpose of 44th Annual J.P. Morgan Healthcare Conference See details
Durability score
High Financial Strength
66.7 / 100
Valuation Score
Mid Valuation
36.2 / 100
Momentum Score
Technically Moderately Bullish
64.6 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM
Analyst Price Target
48
1Yr Price target upside is 11%
9 analysts

12

S

8

W

1

O

1

T

SWOT Analysis

Veracyte Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..